Without help from the global pandemic people may never have been convinced to inject themselves with an experimental mRNA gene therapy, a scientist bragged during a world health conference. Speaking at the opening of the World Health Summit 2021 last November, Bayer Pharmaceuticals Division President Stefan Oelrich admitted were it not for the pandemic, the experimental injection may have seen an extremely high rejection rate. “We are really taking that leap [to drive innovation] – us as a company, Bayer – in cell and gene therapies,” Oelrich stated. “Ultimately, the mRNA vaccines are an example for that cell and gene...
